Skip to content
10-Q

Quarterly Report

VIELA BIO, INC.

0001564590-20-053002

← back to feed
Filed
Nov 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 10, 2020 54.84M sh
Capex Q3 2020 · Sep 30, 2020 $704K
Capex Q3 2020 · Sep 30, 2019 $476K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$97.65M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$69.2M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $111.65M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $200.85M
Stockholders Equity Q3 2020 · Sep 30, 2020 $406.15M
Stockholders Equity Q3 2020 · Jun 30, 2020 $440.22M
Stockholders Equity Q3 2020 · Dec 31, 2019 $354.51M
Stockholders Equity Q3 2020 · Sep 30, 2019 −$259.66M
Stockholders Equity Q3 2020 · Jun 30, 2019 −$212.53M
Stockholders Equity Q3 2020 · Dec 31, 2018 −$188.39M
Current Liabilities Q3 2020 · Sep 30, 2020 $20.66M
Current Liabilities Q3 2020 · Dec 31, 2019 $29.54M
Total Liabilities Q3 2020 · Sep 30, 2020 $21.45M
Total Liabilities Q3 2020 · Dec 31, 2019 $29.54M
Current Assets Q3 2020 · Sep 30, 2020 $403.07M
Current Assets Q3 2020 · Dec 31, 2019 $351.04M
Total Assets Q3 2020 · Sep 30, 2020 $427.6M
Total Assets Q3 2020 · Dec 31, 2019 $384.05M
Sga Expense Q3 2020 · Sep 30, 2020 $14M
Sga Expense Q3 2020 · Sep 30, 2020 $43.69M
Sga Expense Q3 2020 · Sep 30, 2019 $10.23M
Sga Expense Q3 2020 · Sep 30, 2019 $24.58M
Net Income Q3 2020 · Sep 30, 2020 −$37.65M
Net Income Q3 2020 · Sep 30, 2020 −$117.28M
Net Income Q3 2020 · Sep 30, 2019 −$48.41M
Net Income Q3 2020 · Sep 30, 2019 −$74.86M
Operating Income Q3 2020 · Sep 30, 2020 −$38.22M
Operating Income Q3 2020 · Sep 30, 2020 −$120.15M
Operating Income Q3 2020 · Sep 30, 2019 −$48.93M
Operating Income Q3 2020 · Sep 30, 2019 −$76.69M
Revenue Q3 2020 · Sep 30, 2020 $2.32M
Revenue Q3 2020 · Sep 30, 2020 $2.32M
Revenue Q3 2020 · Sep 30, 2019 $20M